Summary
A 55-year old woman was diagnosed as having chronic myeloid leukemia in 1961. After 9 years with stable white blood cells, progression of the disease was noted (white cells up to 180×109/l; splenomegaly to the umbilicus). Busulfan was given over 4 weeks resulting in a remission of 13 years duration. Progression was observed again in 1983, 22 years after the initial diagnosis of chronic myeloid leukemia. Therapy with hydroxyurea resulted in another remission of shorter duration. Two chromosome studies showed the Philadelphia chromosome in 100% of metaphases without additional aberrations. In 1985 blast crisis developed. The cause of death as determined at autopsy was an undiagnosed miliary tuberculosis. The presented case is of special interest since
-
(1)
it is a report of the longest surviving patient with chronic myeloid leukemia, and
-
(2)
in contrast to other cases with long survival, this patient did not show chromosomal mosaicism or any additional chromosomal aberrations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CML:
-
Chronisch-Myeloische Leukämie
- Ph-1:
-
Philadelphia Chromosom
- ALP:
-
Alkalische Leukozytenphosphatase
- Diff BB:
-
Differentialblutbild
Literatur
Appelbaum FR, V Najfeld and JW Singer (1983) Chronic Myelogenous Leukemia: Prolonged Survival with Spontaneous Decline in the Frequency of Ph-1 Positive Cells and Subsequent Development of Mixed Ph-1-Positive and Ph-1 Negative Blast Crisis. Cancer 51:149–153
Bennett M, D Lewis and H Walker (1985) Prolonged Survival in Chronic Granulocytic Leukemia after Busulfan induced Hypoplasia and Karyotype Conversion. Brit J Haematol 59(4):738–740
Bobrowitz ID (1982) Active Tuberkulosis Undiagnosed Untill Autopsy. Amer J Med 72:650–658
Brandt L, F Mitelman, A Panani and HC Lenner (1976) Extremly Long Duration of Chronic Myeloid Leukaemia with Ph-1-Negative and Ph-1-Positive Bone Marrow Cells. Scand J Haematol 16:321–325
Djaldetti M, B Padeh, J Pinkhas and A De Vries (1966) Prolonged Remisson in Chronic Myeloid Leukemia after One Course of Busulphan. Blood 27(1):103–109
Finney R, A McDonald, AG Baikie and AS Douglas (1972) Chronic Granulocytic Leukaemia with Ph-1 Negative Cells in Bone Marrow and a Ten Year Remission after Busulfan Hypoplasia. Brit J Haematol 23:283–288
Golde DW, NL Bersch and RS Sparkes (1976) Chromosomal Mosaicism Associated with Prolonged Remission in Chronic Myelogenous Leukemia. Cancer 37:1849–1852
Gomez GA, JE Sokal and D Walsh (1981) Prognostic Features at Diagnosis of Chronic Myelocytic Leukemia. Cancer 47:2470–2477
Inbal A, E Akstein, I Barak, D Meytes, A Many (1983) Cyclic Leukocytosis and Long Survival in Chronic Myeloid Leukemia. Acta Haematol 69:353–357
Kiley VA, RB Patterson, BA Parsley (1983) Eleven-Year Survival in a Child with Philadelphia Chromosome Positive Chronic Granulocytic Leukemia: Case Report. Military Medicine 148:67–68
Musshoff K, L Boutis, P Obrecht und T Karsch (1969) Die Lebenserwartung der chronischen myeloischen Leukämie in Abhängigkeit von den individuellen und krankheitsspezifischen Faktoren und der Therapie. Klin Wochenschr 47(4):179–183
Rak K, G Csapo, A Macher and G Török (1964) Chronic Granulocytic Leukaemia with Unusual Long Duration. Folia Haematologica 9:131–141
Schilling RF and JJ Crowley (1979) Prognostic Signs in Chronic Myelocytic Leukemia. Amer J Hematol 7:1–10
Singer CRJ, GA McDonald and AS Douglas (1984) Twenty-five year survival of chronic granulocytic leukaemia with spontaneous karyotype conversion. Brit J Haematol 57:309–313
Sokal JE et al. (1984) Prognostic Discrimination in “Good-Risk” Chronic Granulocytic Leukemia. Blood 63(4):789–799
Tharapel SA, GI Plitman, AT Tharapel and RS Wilroy (1986) Philadelphia Chromosome-Positive Chronic Myelocytic Leukemia with a Supplementaryt(4; 9) (q21;p22) and Long Survival. Cancer Genet Cytogenet 21:159–164
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Müller, L., Hehlmann, R. 24 Jahre Überlebenszeit bei chronisch-myeloischer Leukämie. Klin Wochenschr 65, 673–676 (1987). https://doi.org/10.1007/BF01875503
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01875503